ATFA
GSK icon

All Terrain Financial Advisors’s GSK GSK Stock Holding History

All Terrain Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,040
Closed -$61K – 201
2019
Q4 		$61K Hold
1,040
– – 0.02% 192
2019
Q3 		$55K Hold
1,040
– – 0.02% 193
2019
Q2 		$52K Buy
+1,040
New +$52.2K 0.02% 185

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

All Terrain Financial Advisors's GSK Position: Q1 2020 in Review

All Terrain Financial Advisors sold out of GSK (GSK) in Q1 2020, closing a stake of 3,680 shares — an estimated $216K sold.

All Terrain Financial Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters. The position peaked at $248K in Q4 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • All Terrain Financial Advisors reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • All Terrain Financial Advisors sold 3,680 GSK shares in Q1 2020, an estimated $216K.
  • All Terrain Financial Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters.
  • All Terrain Financial Advisors's GSK position peaked at $248K in Q4 2017.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on All Terrain Financial Advisors's 13F filing for Q1 2020, filed 14 May 2020.